07/20/2020

NPF appreciates the Administration’s continued focus on ways to reduce the financial burdens that pharmaceutical costs place on our community, and we appreciate this proposal promoting value-based payment arrangements. While NPF supports the overall aim of the proposed rule to remove regulatory barriers for value-based payment contracts, our letter also expresses concerns regarding other provisions that could negatively affect patient access to potentially life-changing treatments. Our comments and concerns are further outlined in the letter below.